Vanderbilt Eye Institute

Two Vanderbilt Eye Institute physicians have been selected as Emerging Vision Scientists by the Alliance for Eye and Vision Research (AEVR). Read More

Research to Prevent Blindness (RPB) has awarded two grants to faculty in the Department of Ophthalmology. Read More

(photo by John Russell) Among those attending this week’s ribbon cutting and opening of the Vanderbilt Eye Institute at 305 Indian Lake Blvd., Hendersonville, were Vanderbilt University Medical Center’s Paul Sternberg Jr., M.D. (center left), and Titus Daniels, M.D., MPH, MMHC (center right). The clinic relocated from Madison. Read More

When it comes to sun safety, most people are quick to grab a hat and lather on sunscreen. Doctors at the Vanderbilt Eye Institute want consumers to be on the lookout for another protective measure – sunglasses. Read More

Two volunteer leaders have been named to fill top positions on two of the Vanderbilt University Medical Center (VUMC) advisory boards. Read More

Sometimes saying thank you just isn’t enough. Read More

For the past few months, most of the nation has donned hats, boots, scarves and gloves as they have faced brutally cold and icy conditions of winter. As temperatures rise, making outdoor activities more enticing, Vanderbilt ophthalmologists suggest not to be in such… Read More

Since 1961, the Eye Bank Association of America has provided donors for more than 1.5 million corneal transplants nationwide. And for nearly 25 years, the group has celebrated corneal transplant recipients, promoted awareness of the need to donate and recognized donors and families during National Eye Donor Month in March. Read More

The Vanderbilt Eye Institute (VEI) was recently awarded the Commitment to Advocacy Award during the Association of University Professors of Ophthalmology (AUPO) annual meeting. Read More

Tonia Rex, Ph.D., and colleagues at the Vanderbilt Eye Institute are working to uncover how best to treat ocular trauma, the fourth leading cause of blindness worldwide. Read More

Sight is one of the most critical elements of a normal, happy life. When a child’s eyesight is threatened, his or her future stands to be permanently altered — and parents try to find the best treatment available. Read More

Vision science at Vanderbilt has experienced tremendous growth in recent years. Read More

Vanderbilt investigator Anthony Daniels has received a grant from the Knights Templar Eye Foundation to develop new, safe and effective treatments for retinoblastoma, the most common ocular cancer in children. Read More

The Vanderbilt Eye Institute recently received a grant for $115,000 from Research to Prevent Blindness, placing the total award amount for unrestricted grants from the organization at $860,000. Read More

For the past few months, much of the nation has donned hats, boots, scarves and gloves as they face brutally cold and icy conditions of winter. As temperatures rise, making outdoor activities more enticing, Vanderbilt ophthalmologists suggest not to be in such a hurry to stop protecting… Read More

John Penn, Ph.D., Phyllis G and William B. Snyder Endowed Professor of Ophthalmology and Visual Sciences, has been named president-elect of the International Society for Eye Research (ISER). Read More

Vanderbilt Eye Institute’s Initiative for Personalized Medicine in Ophthalmology looks for biomarkers that determine a person’s risk of developing any of the three leading causes of blindness. Read More

Understanding how the protein TRPV1 helps neurons survive after glaucoma-related stressors could lead to new therapeutic strategies for glaucoma and other neurodegenerative conditions. Read More

It’s been 20 years since Project PAVE, a Tennessee program providing low-vision evaluations for children, was launched. Read More

Conventional therapy for patients diagnosed with retinoblastoma, the most common ocular cancer in children, includes systemic chemotherapy, external beam radiation and/or surgical removal of the eye. Doctors at Vanderbilt University Medical Center are on track to radically change the way the disease is treated using an emerging therapeutic approach called intra-arterial chemotherapy, or IA chemo. Read More